We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > 4D

News List

4D Lifetec Secures CHF 23.3 Mio in a Share and Investment Deal with Xlife Sciences Opening New Horizons in Using AI and Digital Health in Early Cancer Detection B3C newswire
November 06, 2023
In a significant financial milestone, Xlife Sciences AG invests CHF 23.3 million in 4D Lifetec AG, acquiring a 20% stake in the company.
Longevity Acquisition Corporation Announces Signing of Definitive Merger Agreement prnasia
October 22, 2020
Longevity Acquisition Corporation, a publicly-traded special purpose acquisition company (SPAC), announced that it has signed a definitive merger agreement with 4D pharma PLC.
4D Announce New Study of MRx0518 in Pancreatic Cancer americanpharmaceuticalreview
January 07, 2020
4D pharma announced the opening of a clinical study to evaluate the safety and preliminary clinical efficacy of MRx0518 in combination with preoperative radiotherapy in 15 patients with resectable pancreatic cancer.
4D pharma Commences Phase I/II Asthma Trial americanpharmaceuticalreview
July 09, 2019
4D pharma has announced an update on its lead Live Biotherapeutic candidate for asthma, MRx-4DP0004.